The host inflammatory response drives much of the pathology, morbidity, and mortality associated with SARS-CoV-2 infection (Merad and Martin, 2020), and Gal-9 was positively correlated with pro-inflammatory mediators and disease severity in COVID-19 patients. Here, LGALS9 is linked to COVID-19.